Comparative study of lung and extrapulmonary poorly differentiated neuroendocrine carcinomas: A SEER database analysis of 162,983 cases

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|124|4|807-815

ISSN： 0008-543x

Source： CANCER, Vol.124, Iss.4, 2018-02, pp. : 807-815

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeted Therapies Provide Treatment Options for Poorly Differentiated Pancreatic Neuroendocrine Carcinomas

By  

Oncology, Vol. 92, Iss. 3, 2016-11 ,pp. : 170-172

Karger

Access to resources Recommend Favorite

Chemotherapy for advanced poorly differentiated pancreatic neuroendocrine carcinoma

By  

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES, Vol. 22, Iss. 8, 2015-08 ,pp. : 623-627

John Wiley & Sons Inc

Access to resources Recommend Favorite

Incidence of secondary malignancies among patients with Waldenström macroglobulinemia: An analysis of the SEER database

By  

CANCER, Vol. 121, Iss. 13, 2015-07 ,pp. : 2230-2236

John Wiley & Sons Inc

Access to resources Recommend Favorite

Survival outcomes of secondary cancers in patients with waldenström macroglobulinemia: An analysis of the SEER database

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 8, 2015-08 ,pp. : 696-701

John Wiley & Sons Inc

Access to resources Recommend Favorite

High-Dose Lanreotide in the Treatment of Poorly Differentiated Pancreatic Neuroendocrine Carcinoma: A Case Report

By  

Case Reports in Oncology, Vol. 7, Iss. 1, 2014-03 ,pp. : 155-163

Karger

Access to resources Recommend Favorite